Trilogy International Partners Inc T.TRL.WT.A

Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.

TSXV:TRL.H - Post by User

Trilogy International Partners Inc

Bullboard Posts

Comment by eSnowdenon Sep 11, 2015 9:05am

120 Views

Post# 24095471

RE:RE:RE:RE:Name change effective immediately.

In the investment community, this is known as "dead money." No impending catalysts to increase the market value, led by a cast-off CEO that is beginning to show why he was fired from Novartis.

Natesto was basically purchased for $25million-- no milestone payments will be collected. Endo has Fortesta for Low-Test, and Auxilium's Testim--both 2x products. How are they going to sell Natesto's 3x product? Instead of wasting a year trying to find a partner, should have taken some of the Estrace sales team and sell it themselves.

And Estrace, CEO says how sales are increasing. At the time the drug was purchased, sales were at $10mm, now they are at $8mm...how is this considered "growth?"

Bullboard Posts

Drilling underway at a large copper-moly porphyry target in Peru